Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.42%
Monthly Change
-18.98%
6 month change
+32.78%
Year Change
+17.73%
Previous Close
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volume
70
Markets
US Stock Market
Healthcare
ZNTL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma CMO Bruns sells $7998 in stock
젠탈리스 제약 PAO, 980만원 상당 주식 매각
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
젠탈리스 파마슈티컬 주가 목표가, Leerink Partners에서 2달러로 하향 조정
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress